Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy
NCT01740271Phase 2Unknown
- Sponsor
- American Health Staffing Group
- Start
- Dec 2012
- Primary completion
- Jun 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of epirubicin in breast cancer, sponsored by American Health Staffing Group. Status: unknown.
02
Drugs
epirubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01740271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740271.